US Stock MarketDetailed Quotes

SER Serina Therapeutics

Watchlist
  • 4.550
  • 0.0000.00%
Close Nov 26 15:49 ET
40.46MMarket Cap-75833P/E (TTM)

About Serina Therapeutics Company

Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.

Company Profile

SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Websitehttp://serinatherapeutics.com/

Company Executives

  • Name
  • Position
  • Salary
  • Steven Ledger
  • Director and Chief Executive Officer
  • 237.50K
  • Dr. Randall W. Moreadith,M.D.,PhD
  • Chief Development Officer
  • 433.88K
  • Gregory S. Curhan
  • Chief Financial Officer
  • --
  • Dr. Srini Tenjarla, PhD
  • Senior Vice President, CMC and Formulation
  • --
  • Dr. Balkrishan Gill, PhD
  • Executive Chairman of the Board
  • --
  • Dr. Simba Gill, PhD
  • Chairman of the Board
  • --
  • Remy Gross
  • Independent Director
  • --
  • Steven M. Mintz
  • Independent Director
  • --
  • J. Milton Harris, PhD
  • Independent Director
  • --
  • Dr. Richard Marshall, M.D.
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data